AVTR
Get informed when a big investor buys or sells
+ FollowUndervalued by 20.8% based on the discounted cash flow analysis.
| Market cap | $9.19 Billion |
|---|---|
| Enterprise Value | $8.92 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.78 |
| Beta | 0.94 |
| Outstanding Shares | 676,200,000 |
| P/E Ratio | -16.2 |
|---|---|
| PEG | 39.41 |
| Price to Sales | - |
| Price to Book Ratio | 1.73 |
| Enterprise Value to Revenue | 1002.46 |
| Enterprise Value to EBIT | -33.85 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 2.5390▼ 1655.88% |
|---|---|
| Total Calls | 14,100▼ 97.07% |
| Total Puts | 35,800▼ 99.61% |
Holdings and activity of institutional investors.
| Ownership % | 22.30%▼ 77.32% |
|---|---|
| Total Invested | $1.50B▼ 71.80% |
| Investors Holding | 207▼ 236.00% |
No data
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.